| Literature DB >> 27399728 |
Louise Montgomery1,2, Jan Seys3, Jan Mees4,5.
Abstract
There is a growing cause for concern on envenoming European species because of jellyfish blooms, climate change and globalization displacing species. Treatment of envenomation involves the prevention of further nematocyst release and relieving local and systemic symptoms. Many anecdotal treatments are available but species-specific first aid response is essential for effective treatment. However, species identification is difficult in most cases. There is evidence that oral analgesics, seawater, baking soda slurry and 42-45 °C hot water are effective against nematocyst inhibition and giving pain relief. The application of topical vinegar for 30 s is effective on stings of specific species. Treatments, which produce osmotic or pressure changes can exacerbate the initial sting and aggravate symptoms, common among many anecdotal treatments. Most available therapies are based on weak evidence and thus it is strongly recommended that randomized clinical trials are undertaken. We recommend a vital increase in directed research on the effect of environmental factors on envenoming mechanisms and to establish a species-specific treatment. Adequate signage on jellyfish stings and standardized first aid protocols with emphasis on protective equipment and avoidance of jellyfish to minimize cases should be implemented in areas at risk.Entities:
Keywords: European; cnidarians; envenomation; jellyfish; nematocyst; pain; relief; stings; treatment
Mesh:
Year: 2016 PMID: 27399728 PMCID: PMC4962017 DOI: 10.3390/md14070127
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Nematocyst structure and mechanism.
List of possible symptoms, location and sting characteristics that have been discussed in reviewed papers.
| Species | Sting Severity | Species Frequency | Area | Cutaneous Symptom | Systemic Symptom | Post-Sting Marking | Reference |
|---|---|---|---|---|---|---|---|
| Scyphozoa | |||||||
| Mild | Low | NA | NRF | NRF | NRF | [ | |
| Mild | Very low | NA | NRF | NRF | NRF | [ | |
| Mild | High | E | Dermatitis | NRF | NRF | [ | |
| Mild | High | MS NA | NRF | NRF | NRF | [ | |
| Mild | Low | NA | NRF | NRF | NRF | [ | |
| High | Low | CS IS MS NS | Wheals | NRF | Multiple punctate linear wheals; | [ | |
| Mild | High | MS NA | NRF | NRF | NRF | [ | |
| Severe* | High | MS NA NS | Burning | Abdominal pain | Red erythematous stripes; | [ | |
| Mild | High | NA NS | NRF | NRF | NRF | [ | |
| Mild | Very low | NA | NRF | NRF | NRF | [ | |
| Mild | Very low | MS | NRF | NRF | NRF | [ | |
| High | Very low | NA | NRF | NRF | NRF | [ | |
| Mild | Low | MS | NRF | NRF | NRF | [ | |
| Mild | Low | NA | NRF | NRF | NRF | [ | |
| Mild | Low | MS NA | NRF | NRF | NRF | [ | |
| Medium | Low | MS | NRF | NRF | NRF | [ | |
| High | Very high | MS | Burning | Anaphylaxis | NRF | [ | |
| Mild | Low-High | NA | NRF | NRF | NRF | [ | |
| Mild | Low | NA MS | NRF | NRF | NRF | [ | |
| Mild | Low | MS | NRF | NRF | NRF | [ | |
| NRF | Low | NS | NRF | NRF | NRF | [ | |
| Mild | High | BS IS NS MS | Erythema | NRF | NRF | [ | |
| Medium | Very low | MS NA | NRF | NRF | NRF | [ | |
| Medium | High | MS | Burning pain | Delayed cutaneous reactions | NRF | [ | |
| NRF | Rare | NA | NRF | NRF | NRF | [ | |
| NRF | Rare | NA | NRF | NRF | NRF | [ | |
| NRF | Rare | NA | NRF | NRF | NRF | [ | |
| Cubozoa | |||||||
| High | High | MS NA | Inflammation | Cardiac complications | NRF | [ | |
| Hydrozoa | |||||||
| Medium | High | MS NA NS | Burning pain | Convulsions | NRF | [ | |
| Medium | Low | MS NA | NRF | NRF | NRF | [ | |
| Severe * | High | MS NA | Atrophy of subcutaneous tissue | Abdominal pain | Linear line of lesions (like a row of beans); | [ | |
Mild: Cutaneous marks, with minimal discomfort which fade after several hours. Medium: Cutaneous reaction, with the threat of some systemic symptoms. High: Cutaneous and systemic symptoms occur more commonly. Severe*: Have been known to rarely result in fatalities with recorded cases of death from systemic complications. E: Europe-wide; MS: Mediterranean Sea; NA: North Atlantic Ocean; CS: Celtic Sea; IS: Irish Sea; NS: North Sea; BS: Black Sea; NRF: no reports found.
Figure 2Schematic diagram of cross-reacting jellyfish species mentioned in publications. The species in grey are currently located outside European waters.
Figure 3Number of publications on envenomation symptoms and treatments found on European jellyfish species.
Figure 4Comparison of the percentage of 63 papers investigating a given treatment, compared to the percentage of papers that concluded beneficial use of the given treatment.
Figure 5The number of conclusions drawn from reviewed papers displaying beneficial (positive effect), ineffective (no effect), or worsening treatments (negative effect) on the jellyfish sting of treatments found in 5% of papers (3 papers) and above.
Conclusive effect of treatment on post-sting treatment for commonly reviewed species with number of papers.
| Treatment | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1− | 1− | |||||||
| 1,1− | 1, 1− | 1− | 1, 3− | |||||
| 1+ | 1− | |||||||
| 1+ | ||||||||
| 1+ | 2+ | |||||||
| 1− | ||||||||
| 2+ | ||||||||
| 1+ | 1+ | 6+ ,1− | ||||||
| 1+ | 1 | |||||||
| 3+ | 2+ | 1− | 2+, 1 | |||||
| 1− | ||||||||
| 4+ | 2+ | 2+ | 1+ | |||||
| 1 | 2+ | 2+ | 4+, 1 | |||||
| 1+ | 1+, 1 | 2+ | 1+, 1− | 1+ | 1+ | 4+, 2− | ||
| 1+ | ||||||||
| 1, 1− | ||||||||
| 1+ | ||||||||
| 1+ | 1+ | 2+ | 3+ | 1+ | ||||
| 1+ | ||||||||
| 1+ | 1+ | 2+ | ||||||
| 1− | ||||||||
| 1− | ||||||||
| 1− | 1+ | 1+, 4− | 2+, 3− | 3+ | 6+, 1, 6− | |||
| 1+ | ||||||||
| 1+ | ||||||||
| Key: | Overall positive effect (+) | Overall no effect | Overall negative effect (−) | |||||
Figure 6(a) Obis, E. Carybdea marsupialis are small transparent box jellyfish with a tentacle on each of the four corners. Photograph reproduced with permission from LIFE CUBOMED project (LIFE08 NAT/ES/0064) and the photographer Eduardo Obis [67]; (b) de Wulf, L. Chrysaora hysoscella is white-yellow with 16 brown paired bands on the bell surface.